The development and new perspectives of stroke treatment in Poland
DOI:
https://doi.org/10.15584/medrev.2015.4.5Keywords:
ischemic stroke, treatment, thrombolysis, mechanical thrombectomyAbstract
Stroke is one of the few neurological disorders known since antiquity. It is a clinical syndrome characterized by a sudden focal, and sometimes generalized brain dysfunction whose symptoms persist for more than 24 hours or sooner leads to death and has no other reason than vascular. This disease is common, approximately 15 million people fall ill with a stroke a year. In developed countries it is the third most common cause of adult disability and the second cause of dementia syndromes. The article presents the history of treatment of a stroke in Poland from the first mention in the textbooks on neurology from the 50’s to the present time. The past two decades proved to be the breakthrough in the treatment of strokes, when a significant change in the approach to this disease was adopted. Stroke from a hopeless state has become an acute illness, on the treatment of which neurologists have an increasing impact. Initially, the treatment of a stroke involved only patient care and prevention of systemic complications and bedsores. It was not until the 2nd half of the 90’s of the twentieth century that specialized stroke units were established, providing comprehensive care for patients. A breakthrough was an introduction of the rt-PA -recombinant tissue plasminogen activator to the treatment whose task is recanalization of a vessel closed by a blood clot or embolism in the acute period of the disease. This treatment significantly improved the functional status of patients. For the last several years, the concept of mechanical recanalization of the intracranial vascular system has developed, whose first tests have been conducted in several centers in Poland.
Downloads
References
Litwin T, Członkowska A. Udary mózgu – wprowadzenie. W: Stępień A. (red.). Neurologia, Warszawa, Medical Tribune Polska 2014; tom II, 171–188.
Litwin T, Członkowska A. Ostre niedokrwienie mózgu – udar niedokrwienny i przemijające niedokrwienie mózgu. W: Stępień A. (red.) Neurologia, Warszawa, Medical Tribune Polska 2014; tom II, 189–215.
Opalski A. Leczenie udaru mózgowego i jego następstw. W: Opalski A. Choroby ośrodkowego układu nerwowego pochodzenia naczyniowego i choroby starcze. Warszawa, PZWL 1951; 60–61.
Gajkowski K. Leczenie chorób naczyniowych mózgu. W: Domżał T. (red.). Leczenie Chorób Układu Nerwowego. Warszawa, PZWL 1975; 41–46.
Prusiński A. Choroby naczyniowe mózgu. W: Prusiński A. Podstawy Neurologii Klinicznej. Warszawa, PZWL 1977; 150–166.
Hołyst J. Leczenie zachowawcze. W: Hołyst J. Niedostateczność krążenia krwi w mózgowiu. Warszawa, PZWL 1971; 170–173.
Kwolek A. Historia rehabilitacji neurologicznej w Polsce. W: Jandziś S, Kwolek A. Rozwój rehabilitacji w wybranych specjalnościach medycznych w Polsce. Rzeszów, Wyd U Rz 2014; 109–132.
Jankowicz E. Choroby naczyniopochodne układu nerwowego. W: Hausmanowa-Petrusewicz I. (red.). Leczenie układu nerwowego. Warszawa, PZWL 1990; 28–42.
Członkowska A, Ryglewicz D, Weissbein T. i wsp. A prospective community – based study of stroke in Warsow. Poland, Stroke 1994; 25: 547-551.
Postępowanie w Ostrym Udarze Niedokrwiennym Mózgu: Raport zespołu ekspertów Narodowego Programu Profilaktyki i Leczenia Udaru Mózgu. Neurol Neurochir Pol 1999; 33, supl. 4: 13-60.
Aboderin I, Venables G. Stroke management in Europe. Pan European Consensus Meeting on Stroke Management. J Intern Med 1996; 240: 173-180.
Stroke Unit Trialists Collaboration. Organized inpatient (stroke unit) care for stroke. Cochrane Database of Systematic Reviews, 2013 Issue 2009. Art. No.: CD000197.
Członkowska A, Milewska D, Ryglewicz D. The Polish experience in early stroke care. Cerebrovasc Dis 2003; 15 (suppl 1): 14-15.
Wahlgren N, Ahmed N, Davalos A i wsp. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST). Lancet 2007; 369: 275-282.
Hacke W, Kaste M, Fieschi C i wsp. Intravenous thrombolysis with recombinant tissue Plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA 1995; 274: 1017-1025.
Steiner T, Bluhmki E, Kaste M, Toni D i wsp. The ECASS 3-hour kohort. Secondary analysis of ECASS data by time stratification. ECASS Study Group. European Cooperative Acute Stroke Study. Cerebrovasc Dis 1998; 8: 198-203.
Hacke W, Kaste M, Fieschi C i wsp. Randomised double-blind placebo-controlled trial of thrombolytic therapy whith intravenous alteplase in acute ischemic stroke (ECASS II). Lancet 1998; 352: 1245-1251.
Gąsecki D, Kozera G, Mierzejewski L i wsp. Wczesna rekanalizacja tętnicy środkowej mózgu w leczeniu fibrynolitycznym kardiogennego udaru mózgu - opis przypadku. Udar Mózgu 2003; 5: 7–12.
Czlonkowska A, Kobayashi A, Skowronska M, Niewada M, Sarzynska-Dlugosz I. Thrombolysis for stroke in Poland: first 2 years of experience. Int. J. Stroke 2006; 1: 111–112.
Dworakowski R, Mierzejewski L, Gąsecki D i wsp. Udar niedokrwienny mózgu u chorej z napadowym migotaniem przedsionków. Leczenie fibrynolityczne. Postępowanie diagnostyczne i lecznicze. Kardiol. Pol 2002; 56: 316–320.
The National Institute of Neurological Disorders and Stroke (NINDS) rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995; 333: 1581–1587.
Hacke W, Kaste M, Bluhmki E. i wsp. Thrombolysis with Alteplase 3 to 4,5 Hours after Acute Ischaemic Stroke. N.Engl J Med 2008; 359: 1317-1329.
Grupa Ekspertów Sekcji Chorób Naczynowych Polskiego Towarzytw Neurologicznego. Potępowanie w udarze mózgu – Wytyczne Grupy Ekspertów Sekcji Chorób Naczyniowych Polskiego Towarzystwa Neurologicznego. Neurol Neuroch Pol 2012; 46, 1 (supl.1): 16-62.
The IST-3 collaborative group. The benefits and harms of intravenous thrombolysis with recombinant tissue plazminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial. Lancet 2012; 379: 2352-2363.
el Zoppo GJ, Higashida RT, Furlan AJ, et al. PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arteria delivery in acute middle cerebral artery stroke. PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism. Stroke 1998; 29: 4-11.
Furlan A, Higashida R, Wechsler L, et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 1999; 282: 2003-2011.
Smith WS, Sung G, Starkman S, et al. Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke 2005; 36: 1432-1438.
Smith WS, Sung G, Saver J, et al. Mechanical thrombectomy for acute ischemic stroke: final results of the Multi MERCI trial. Stroke 2008; 39: 1205-1212.
The Penumbra Pivotal Stroke Trial Investigators. The Penumbra Pivotal Stroke Trial. Stroke 2009; 40: 2761-2768.
Davalos A, Pereira VM, Chapot R, et al. Retrospective multicenter study of solitaire FR for revascularization in the treatment of acute ischemic stroke. Stroke 2012; 43: 2699-2705.
Saver JL, Jahan R, Levy EI, et al. Solitaire flow restoration device versus the Merci Retriever in patients with acute ischaemic stroke (SWIFT): a randomised, parallel-group, non-inferiority trial. Lancet 2012; 380 (9849): 1241-1249.
Broderick JP, Palesch YY, Demchuk AM, et al. Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N Engl J Med 2013; 368: 893–903.
Kidwell CS, Jahan R, Gornbein J, et al. A trial of imaging selection and endovascular treatment for ischemic stroke. N Engl J Med 2013; 368: 914–923.
Demchuk AM, GoyalM, Yeatts SD, et al. Recanalization and clinical outcome of occlusion sites at baseline CT angiography in the Interventional Management of Stroke III trial. Radiology 2014; 273(1): 202–210.
Ciccone A, Valvassori L, Nichelatti M, et al. Endovascular treatment for acute ischemic stroke. N Engl J Med 2013; 368: 904–913.
Nogueira R.G, Gupta R, Davalos A. IMS-III and SYNT HESIS expansion trials of endovascular therapy in acute ischemic stroke: how can we improve? Stroke 2013; 44: 3272–3274.
Berkhemer OA, Fransen PS, Beumer D. MR CLEAN Investigators. N Engl J Med. 2015; 372: 11-20.
Campbell BCV, Mitchell PJ, Kleinig TJ, et al. Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med 2015; 372: 1009–1018.
Saver JL, Goyal M, Bonafe A. et al. Stent-retriever thrombectomy after intravenous t-PA vs. t- PA alone in stroke. N Engl Jmed 2015; 372: 2285-2295.
Goyal M, Demchuk AM, Menon BK. Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med 2015; 372: 1019-1030.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2015 Medical Review
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our open access policy is in accordance with the Budapest Open Access Initiative (BOAI) definition: this means that articles have free availability on the public Internet, permitting any users to read, download, copy, distribute, print, search, or link to the full texts of these articles, crawl them for indexing, pass them as data to software, or use them for any other lawful purpose, without financial, legal, or technical barriers other than those inseparable from having access to the Internet itself.
All articles are published with free open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0). If you submit your paper for publication by the Eur J Clin Exp Med, you agree to have the CC-BY license applied to your work. Under this Open Access license, you, as the author, agree that anyone may download and read the paper for free. In addition, the article may be reused and quoted provided that the original published version is cited. This facilitates freedom in re-use and also ensures that Eur J Clin Exp Med content can be mined without barriers for the research needs.
